Sunil Babu
Impact in
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
- Hematology top 5%
- Acute Myeloid Leukemia Research
Papers in
- Oncology 17
- CAR-T cell therapy research 7
- Cancer Immunotherapy and Biomarkers 6
- Lung Cancer Research Studies 4
-
- Lymphoma Diagnosis and Treatment 10
- Co-authors
- Edward B. Garon (4 shared papers)Yahsou Delmas (4 shared papers)Camille L. Bedrosian (4 shared papers)Neil Sheerin (4 shared papers)Jason C. Chandler (2 shared papers)Larry A. Greenbaum (4 shared papers)David Waterhouse (2 shared papers)Robert M. Jotte (2 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Blood (10 papers)Journal of Thoracic Oncology (3 papers)Clinical Cancer Research (2 papers)Hematological Oncology (2 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Sunil Babu
40 papers receiving 1.3k citations
Sunil Babu's Hit Papers
Peers
Comparison fields: 5 of 74
- Nephrology 160
- Hematology 254
- Oncology 536
- Immunology 428
- Transplantation 36
Countries citing papers authored by Sunil Babu
This map shows the geographic impact of Sunil Babu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunil Babu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunil Babu more than expected).
Fields of papers citing papers by Sunil Babu
This network shows the impact of papers produced by Sunil Babu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunil Babu. The network helps show where Sunil Babu may publish in the future.
Co-authors
The 25 scholars most cited alongside Sunil Babu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 308 | |
| 2 | 2018 | 184 | |
| 3 | 2021 | 140 | |
| 4 | 2022 | 81 | |
| 5 | 2017 | 76 | |
| 6 | Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine Hit paper breakdown → | 2024 | 57 |
| 7 | 2017 | 57 | |
| 8 | 2022 | 50 | |
| 9 | 2020 | 44 | |
| 10 | 2020 | 33 | |
| 11 | 2022 | 33 | |
| 12 | 2012 | 30 | |
| 13 | 2020 | 30 | |
| 14 | 2022 | 28 | |
| 15 | Phase 2 Open-Label Study of Sacituzumab Govitecan as Second-Line Therapy in Patients With Extensive-Stage SCLC: Results From TROPiCS-03 Hit paper breakdown → | 2025 | 24 |
| 16 | 2017 | 21 | |
| 17 | 2021 | 16 | |
| 18 | 2022 | 14 | |
| 19 | 2019 | 10 | |
| 20 | 2023 | 9 |
About Sunil Babu
Sunil Babu is a scholar working on Oncology, Pathology and Forensic Medicine, Genetics, Immunology and Pulmonary and Respiratory Medicine, having authored 45 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), CAR-T cell therapy research (7 papers), Chronic Lymphocytic Leukemia Research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Complement system in diseases (5 papers), Acute Myeloid Leukemia Research (4 papers), Lung Cancer Research Studies (4 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Nephrology (160 citations), Hematology (254 citations), Oncology (536 citations), Immunology (428 citations) and Transplantation (36 citations). Sunil Babu has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Edward B. Garon, Yahsou Delmas, Camille L. Bedrosian, Neil Sheerin, Jason C. Chandler, Larry A. Greenbaum, David Waterhouse, Robert M. Jotte, David J. Cohen and Christophe Legendre. Their work appears in journals such as Journal of Clinical Oncology, Blood, Journal of Thoracic Oncology, Clinical Cancer Research and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.